AI Article Synopsis
Article Abstract
Background: Intraluminal tracheal stenting is a minimally invasive procedure shown to have variable degrees of success in managing clinical signs associated with tracheal collapse syndrome (CTCS) in dogs.
Objectives: Identify immediate post-stent changes in tracheal diameter, determine the extent of stent migration, and stent shortening after stent placement in the immediate-, short-, and long-term periods, and evaluate inter-observer reliability of radiographic measurements.
Animals: Fifty client-owned dogs.
Methods: Retrospective study in which medical records were reviewed in dogs with CTCS treated with an intraluminal tracheal stent. Data collected included signalment, location, and type of collapse, stent diameter and length, and post-stent placement radiographic follow-up times. Radiographs were used to obtain pre-stent tracheal measurements and post-stent placement measurements.
Results: Immediate mean percentage change was 5.14%, 5.49%, and 21.64% for cervical, thoracic inlet, and intra-thoracic tracheal diameters, respectively. Ultimate mean follow-up time was 446 days, with mean percentage change of 2.55%, 15.09%, and 8.65% for cervical, thoracic inlet, and intra-thoracic tracheal diameters, respectively. Initial mean stent length was 26.72% higher than nominal length and ultimate long-term tracheal mean stent shortening was only 9.90%. No significant stent migration was identified in the immediate, short-, or long-term periods. Good inter-observer agreement of radiographic measurements was found among observers of variable experience level.
Conclusions And Clinical Importance: Use of an intraluminal tracheal stent for CTCS is associated with minimal stent shortening with no clinically relevant stent migration after fluoroscopic placement. Precise stent sizing and placement techniques likely play important roles in avoiding these reported complications.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867008 | PMC |
| http://dx.doi.org/10.1111/jvim.15063 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endobronchial stenting in a rare case of severe necrotic tracheal mucormycosis.
Lung India
January 2025
Department of Respiratory Medicine, KMCH, Coimbatore, Tamil Nadu, India.
We present a case of tracheal necrosis due to mucormycosis in a young diabetic male. He presented with stridor due to airway obstruction from the necrosed tracheal wall. We used a silicon tracheal stent to maintain airway patency and support the airway.
View Article and Find Full Text PDFSilicone stent versus fully covered metallic stent in tracheoesophageal fistula: a single-center retrospective study.
BMC Pulm Med
December 2024
Department of Pulmonary and Critical Care Medicine, Jining NO.1 People's Hospital, Jining, Shandong, PR China.
Background: In cases of tracheoesophageal fistula (TEF), closure of the fistula by tracheal stent implantation is an effective treatment. In this study, we investigated the efficacy and complications of silicone and metallic tracheal stents for TEF.
Methods: We retrospectively reviewed all patients who underwent tracheal stent insertion for TEF between January 2021 and April 2024 at our institution.
Tracheobronchopathia osteoplastica: a clinical case report of a 63-year-old man.
Front Med (Lausanne)
November 2024
Department of Gastroenterology, Ankang Central Hospital, Ankang, Shaanxi, China.
Article Synopsis
- - Tracheobronchopathia osteoplastica (TO) is a rare benign airway condition involving abnormal bone and cartilage growth in the trachea and bronchi, often diagnosed through biopsy.
- - A case study of a 63-year-old male with symptoms like coughing and hemoptysis highlighted the importance of identifying TO, though its exact cause remains unknown and may relate to chronic issues.
- - While TO typically has a slow progression and good prognosis, symptoms can worsen over time, making early diagnosis and management strategies, like inhaled glucocorticoids and interventional therapies, essential.
Treatment of recurrent tracheal adenoid cystic carcinoma with a covered airway stent loaded with Iodine-125 seeds: a 5-year follow-up case report.
Front Oncol
November 2024
Department of Respiratory and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Background: The treatment of recurrent tracheal adenoid cystic carcinoma (TACC), a rare pulmonary malignant tumor, typically involves bronchoscopic interventional therapy for patients ineligible for surgery or external radiotherapy. This report describes an innovative treatment approach for TACC, initially managed with interventional bronchoscopy and subsequently with a Y-shaped airway stent loaded with I seeds, following recurrence after 2 years.
Case Presentation: A 50-year-old man presented with intermittent coughing for 2 months and was admitted to the hospital after the discovery of TACC a month earlier.
Plasma Surface Modification of the Inner Wall of Montgomery's Tracheal Implant (T-Tube).
Polymers (Basel)
November 2024
São José dos Campos Institute of Science and Technology (ICT), São Paulo State University (UNESP), São José dos Campos 12245-000, SP, Brazil.
Tracheal stenosis (i.e., the abnormal narrowing of the trachea) can occur due to a variety of inflammatory and infectious processes as well as due to therapeutic procedures undertaken by the patient.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!